Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 116, 2011 - Issue 3
Journal homepage
482
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Platelet kinetics after slow versus standard transfusions: A pilot study

Abbas HabibiImam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
,
Mohsen EsfandbodImam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
,
Mohammad Hossein GhafariImam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
,
Patricia KhashayarEndocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
,
Atabak NajafiSina Hospital, Tehran University of Medical Sciences, Tehran, Iran
&
Reza Shariat MoharariSina Hospital, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected] [email protected]
Pages 212-215 | Received 21 Jun 2010, Accepted 02 Mar 2011, Published online: 17 Jun 2011

References

  • Wu KK, Thompson JS, Koepke JA, Hoak JC, Flink R. Heterogeneity of antibody response to human platelet transfusion. J Clin Invest. 1976;58:432.
  • Novotny VMJ. Prevention and management of platelet transfusion refractoriness. Vox Sanguinis. 1999;76:1–13.
  • Alcorta I, Pereira A, Ordinas A. Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study. Br J Haematol. 1996;93:220–4.
  • McCullough J, Steeper TA, Connelly DP, Jackson B, Huntington S, Scott EP. Platelet utilization in a university hospital. JAMA. 1998;259:2414–18.
  • Snyder EL, Rinder HM, Napychank P. In vitro and in vivo evaluation of platelet transfusions administered through an electromechanical transfusion pump. Am J Clin Pathol. 1990;94:77–80.
  • Narvios A, Reddy V, Martinez F, Lichtiger B. Slow infusion of platelet: A possible alternative in the management of refractory thrombocytopenic patients. Am J Hematol. 2005;79:80.
  • Murphy MF, Waters AH. Platelet transfusions: The problem of refractoriness. Blood Rev. 1990;4:16–24.
  • Shulman NR. Immunological considerations attending platelet transfusion. Transfusion. 1966;6:39–49.
  • Sandler SG. Alloimmune refractoriness to platelet transfusions. Curr Opin Hematol. 1997;4:470–3.
  • Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Rev Med Chil. 1997;125:1305–12.
  • Delaflor-Weiss E, Mintz PD. The evaluation and management of platelet refractoriness and alloimmunization. Transfus Med Rev. 2000;14:180–96.
  • Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of ‘hypersplenic’ thrombocytopenia. J Clin Invest. 1966;45:645–57.
  • Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39:103–6.
  • Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med. 1997;337:1861–9.
  • Vassallo RR. New paradigms in the management of alloimmune refractoriness to platelet transfusions. Curr Opin Hematol. 2007;14:655–63.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.